DiscoverThe Itch: Allergies, Asthma, Eczema & Immunology#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial
#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

Update: 2025-10-30
Share

Description

Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.


In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”


What we cover in our episode about dupilumab and mucus plugging

  • Why mucus plugging matters in asthma: Discover how thick, sticky mucus can block airways, make it harder to breathe, and why standard inhalers and steroids don’t clear these plugs.

  • How dupilumab may help: Learn how this biologic blocks IL-4 and IL-13, two key drivers of type 2 inflammation that increase mucus production and thickness.

  • Inside the VESTIGE study: Hear how researchers measured mucus burden using CT scans and “mucus plug scores” to see if dupilumab could reduce plugging in moderate-to-severe asthma.

  • What the results showed: Find out how dupilumab lowered mucus plug scores, reduced airway inflammation, and improved lung function (FEV₁), especially in people with high mucus burden.

  • What this means for patients: Learn why identifying and treating mucus plugging may help improve breathing, reduce flare-ups, and make asthma easier to manage day to day.


📌INFOGRAPHIC to follow along 


RESOURCES:



The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.


___


A special collaboration with the American Thoracic Society. 


This podcast was made in partnership with Allergy & Asthma Network.


This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.


 


 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

The Itch: Allergies, Asthma & Immunology